Clinical trial
Effect of Refnot on Immunity in Cancer Patients
NCT05898451 is registered in ClinicalTrials.gov with Refnot-Pharm Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Refnot on Immunity in Cancer Patients
- Lead sponsor
- Refnot-Pharm Ltd
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 4, 2009
- Completion date
- November 30, 2011
- Enrollment
- 55 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumor